Intrauterine tissue removal

TruClear™ hysteroscopic tissue removal system

Intrauterine tissue removal

TruClear™ hysteroscopic tissue removal system

The TruClear™ system offers a complete solution for diagnosing and treating intrauterine abnormalities that may be causing abnormal uterine bleeding.

Description

The TruClear™ system offers a flexible solution to your hysteroscopic procedures, both in the OR and the office. It includes features such as customizable resection speeds, suction control, and a variety of compatible blade style options.

The TruClear™ system includes the control unit, handpiece, and footswitch. When used with our TruClear™ hysteroscopes and tissue shavers, the complete platform provides direct visualization of the uterine cavity with targeted resection of abnormal tissue.1

The TruClear™ system is designed for the treament of abnormal uterine bleeding caused by abnormalities such as polyps, fibroids, and retained products of conception. When considering future fertility, treatment options that preserve the uterus are important to consider.

Preserving what matters: the uterus.

Resect uterine tissue

The TruClear™ system is indicated for polyps, fibroids, and retained products of conception. Our various blade options work in tandem with the fluid management system to resect and  evacuate abnormal tissue. While the blade resects, integrated suction technology simultaneously removes debris to keep the field of view clear during the entire procedure.

Preserves uterine function

The TruClear™ hysteroscopic tissue removal system uses a mechanical approach to remove intrauterine pathology. Unlike electrical resection, this system does not cause scarring from thermal energy or energy discharge. This procedure does not require major surgery and can also be performed in an office setting.

Ordering information

Item number Description Units per box
7209808 TruClear™ control unit 1
7209820 TruClear™ footswitch 1
7209807 TruClear™ handpiece 1

Adverse effects for operative hysteroscopy include but are not limited to fluid overload due to intravasation and uterine perforation. Please refer to Instructions for Use (IFU) for complete contraindication and risk information. Residual risks to the patients may include but are not limited to exposure to body fluids, fetal distress, metastasis (cancer), peritonitis, abscess, and electric shock.

  1. Smith PP, Middleton LJ, Connor M, Clark TJ. Hysteroscopic morcellation compared with electrical resection of endometrial polyps: a randomized controlled trial. Obstet Gynecol. 2014 Apr;123(4):745-51.